Cell and gene therapy regulation
The regulation of cell and gene therapies is intricate and the rapid advancement of these technologies continuously influences the regulatory and operational framework, presenting unique challenges and opportunities for regulators, developers and manufacturers.
Additionally, regulatory authorities strive for harmonization worldwide, but categorize these therapies differently, requiring manufacturers to navigate region-specific regulations and terminology.
This Spotlight, in association with Sartorius, delves into the evolving regulatory landscape of cell and gene therapies, exploring the complexities and nuances that shape their approval and commercialization.
This feature was produced in association with Sartorius.
